Sedation in Palliative Care—a Clinically Oriented Overview of Guidelines and Treatment Recommendations

Overview

Journal Dtsch Arztebl Int

Specialties General Medicine
Public Health

Date 2023 Feb 28

PMID 36851822

Authors

Carsten Klein

Rafaela Voss

Christoph Ostgathe

Jan Ansgar Schildmann

Affiliations

Soon will be listed here.

Abstract

Background: The appropriate provision of sedation as a last resort for the relief of suffering in palliative care is dealt with variably in actual practice. This article is intended as an overview of practically relevant information found in treatment recommendations and guidelines.

Methods: A systematic literature search was conducted in the PubMed, Scopus, and Google Scholar databases, and a manual search was carried out online. Recommendations that were not available in either German or English, or that were specific to pediatric practice, were excluded. Publication quality was assessed with the AGREE II instrument (Appraisal of Guidelines for Research & Evaluation II). The recommendations in the documents were qualitatively evaluated.

Results: 29 publications (11 journal articles, 18 other) of varying quality according to AGREE II were included. All recommendations and guidelines were essentially based on expert consensus. The common indications for sedation are otherwise intractable delirium, dyspnea, and pain, in patients with a life expectancy of no more than two weeks. Existential distress is a controversial indication. The drug of first choice is midazolam. As the sedating effect of opioids is hard to predict, they should not be used as sedatives. The risks of sedation include respiratory and circulatory depression, as well as the loss of communicative ability, control, and autonomy. It is generally recommended that the patient's symptom burden and depth of sedation should be monitored; clinical and technically supported monitoring are recommended in some publications as well, depending on the situation.

Conclusion: There is a broad consensus in favor of sedation to relieve suffering in the last days and hours of life. Recommendations vary for patients with a longer life expectancy and for those with existential distress, and with respect to monitoring.

Citing Articles

Evaluating physicians' knowledge of assisted suicide and palliative sedation therapy in Austria : An exploratory survey study.

Fischer L, Le N, Kirchner S, Feichtner A, Falkner A, Masel E Wien Klin Wochenschr. 2025; .

PMID: 40035840 DOI: 10.1007/s00508-025-02509-7.

Development of a Complex Intervention to Support the Use of Sedative Drugs in Specialist Palliative Care (iSedPall).

Kauzner S, Schneider M, Heckel M, Klein C, Bausewein C, Schildmann E Palliat Med Rep. 2025; 5(1):527-536.

PMID: 40012852 PMC: 11864855. DOI: 10.1089/pmr.2024.0042.

Neurology and physician-assisted suicide: glossary of definitions and terminology.

Solari A, Ticozzi N, Comi G, Mancardi G, Provinciali L, Padovani A Neurol Sci. 2025; .

PMID: 40009146 DOI: 10.1007/s10072-025-08064-3.

Expert-approved best practice recommendations on the use of sedative drugs and intentional sedation in specialist palliative care (SedPall).

Ostgathe C, Bausewein C, Schildmann E, Bazata J, Handtke V, Heckel M BMC Palliat Care. 2023; 22(1):126.

PMID: 37667303 PMC: 10476406. DOI: 10.1186/s12904-023-01243-z.

References

Twycross R . Reflections on palliative sedation. Palliat Care. 2019; 12:1178224218823511. PMC: 6350160. DOI: 10.1177/1178224218823511. View

Ciais J, Jacquin P, Pradier C, Castelli-Prieto M, Baudin S, Tremellat F . Using Sodium Oxybate (Gamma Hydroxybutyric Acid) for Deep Sedation at the End of Life. J Palliat Med. 2015; 18(10):822. DOI: 10.1089/jpm.2015.0221. View

Brouwers M, Kerkvliet K, Spithoff K . The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016; 352:i1152. PMC: 5118873. DOI: 10.1136/bmj.i1152. View

Hofherr M, Abrahm J, Rickerson E . Dexmedetomidine: A Novel Strategy for Patients with Intractable Pain, Opioid-Induced Hyperalgesia, or Delirium at the End of Life. J Palliat Med. 2020; 23(11):1515-1517. DOI: 10.1089/jpm.2019.0427. View

Kissane D . The relief of existential suffering. Arch Intern Med. 2012; 172(19):1501-5. DOI: 10.1001/archinternmed.2012.3633. View

Schildmann E, Meesters S, Bausewein C . Sedatives and Sedation at the End of Life in the Hospital. Dtsch Arztebl Int. 2022; 119(21):373-379. PMC: 9487710. DOI: 10.3238/arztebl.m2022.0194. View

Schur S, Weixler D, Gabl C, Kreye G, Likar R, Masel E . Sedation at the end of life - a nation-wide study in palliative care units in Austria. BMC Palliat Care. 2016; 15:50. PMC: 4868021. DOI: 10.1186/s12904-016-0121-8. View

Hagemann V, Bausewein C, Remi C . Drug use beyond the licence in palliative care: A systematic review and narrative synthesis. Palliat Med. 2019; 33(6):650-662. DOI: 10.1177/0269216319840602. View

Belar A, Arantzamendi M, Payne S, Preston N, Rijpstra M, Hasselaar J . How to measure the effects and potential adverse events of palliative sedation? An integrative review. Palliat Med. 2020; 35(2):295-314. PMC: 7897792. DOI: 10.1177/0269216320974264. View

10.

Bozzaro C, Schildmann J . "Suffering" in Palliative Sedation: Conceptual Analysis and Implications for Decision Making in Clinical Practice. J Pain Symptom Manage. 2018; 56(2):288-294. DOI: 10.1016/j.jpainsymman.2018.04.003. View

11.

Kirk T, Mahon M . National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage. 2010; 39(5):914-23. DOI: 10.1016/j.jpainsymman.2010.01.009. View

12.

Schildmann E, Schildmann J . Palliative sedation therapy: a systematic literature review and critical appraisal of available guidance on indication and decision making. J Palliat Med. 2014; 17(5):601-11. DOI: 10.1089/jpm.2013.0511. View

13.

Surges S, Garralda E, Jaspers B, Brunsch H, Rijpstra M, Hasselaar J . Review of European Guidelines on Palliative Sedation: A Foundation for the Updating of the European Association for Palliative Care Framework. J Palliat Med. 2022; 25(11):1721-1731. DOI: 10.1089/jpm.2021.0646. View

14.

Cherny N . ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation. Ann Oncol. 2014; 25 Suppl 3:iii143-52. DOI: 10.1093/annonc/mdu238. View

15.

Klein C, Wittmann C, Wendt K, Ostgathe C, Stiel S . [Palliative sedation : Development and consensus of a German language documentation template]. Anaesthesist. 2018; 67(7):504-511. DOI: 10.1007/s00101-018-0451-4. View

16.

Abarshi E, Rietjens J, Robijn L, Caraceni A, Payne S, Deliens L . International variations in clinical practice guidelines for palliative sedation: a systematic review. BMJ Support Palliat Care. 2017; 7(3):223-229. DOI: 10.1136/bmjspcare-2016-001159. View

17.

Stiel S, Nurnus M, Ostgathe C, Klein C . Palliative sedation in Germany: factors and treatment practices associated with different sedation rate estimates in palliative and hospice care services. BMC Palliat Care. 2018; 17(1):48. PMC: 5851294. DOI: 10.1186/s12904-018-0303-7. View

18.

Arantzamendi M, Belar A, Payne S, Rijpstra M, Preston N, Menten J . Clinical Aspects of Palliative Sedation in Prospective Studies. A Systematic Review. J Pain Symptom Manage. 2020; 61(4):831-844.e10. DOI: 10.1016/j.jpainsymman.2020.09.022. View

19.

Morita T, Kawahara T, Stone P, Sykes N, Miccinesi G, Klein C . Intercountry and intracountry variations in opinions of palliative care specialist physicians in Germany, Italy, Japan and UK about continuous use of sedatives: an international cross-sectional survey. BMJ Open. 2022; 12(4):e060489. PMC: 9036469. DOI: 10.1136/bmjopen-2021-060489. View

20.

Sulmasy D . The last low whispers of our dead: when is it ethically justifiable to render a patient unconscious until death?. Theor Med Bioeth. 2018; 39(3):233-263. DOI: 10.1007/s11017-018-9459-7. View